The Navigator Company (NVG) Q4 2025 earnings summary

Executive summary

• Maintained strong market position and grew volumes despite global economic uncertainty, trade tariffs, and the toughest market in decades, leveraging international footprint and diversified business model.

• Portfolio transformation, operational flexibility, and sustainability focus underpinned resilience and competitive advantage.

• Strategic diversification into tissue and packaging segments cushioned results, now accounting for 29% of turnover and 32% of EBITDA.

• Major investments and international expansion since 2019 have strengthened core business and diversified earnings.

• Best-ever safety performance achieved, with frequency index at international benchmark levels.

Financial highlights

• Revenue for 2025 was €1,970M (down 5.7% YoY); EBITDA €376M (down 31.3%), with a 19% margin; EBIT €208M (down 45.2%).

• Net earnings €145M (down 49.6% YoY); Free cash flow €89M (up from €23M); Capex €210M, with 60% directed to sustainability investments.

• Net debt stood at €704M, Net Debt/EBITDA at 1.87x, equity ratio 44.3%.

• Liquidity at year-end was €390M; average cost of finance was 2.7%.

• Board proposes €80M in dividends for 2025.

Outlook and guidance

• Cautiously optimistic for 2026, expecting firmer pulp and paper prices in H1 and stabilization in H2.

• Demand in 2026 projected to be similar to 2025, with growth in China offsetting flat Europe.

• Limited new supply expected in 2026; most new capacity to impact 2027.

• Price increases in paper segments expected to support margins in early 2026.

• Tissue and Packaging segments expected to maintain growth; new Tissue machine investment planned for Aveiro, startup in 2028.